CHaD Research Study Aims to Prevent Flu in Children
October 28, 2010
As part of a National Institutes of Health-sponsored study comparing treatment plans to prevent influenza in children, Dartmouth pediatrician Peter F. Wright, M.D., is inviting the parents of children ages 2 to 9 to bring the youngsters to the Children's Hospital at Dartmouth (CHaD) to participate in a study aimed at developing the best treatment plan to prevent influenza in children.
This year the Center for Disease Control and Prevention (CDC) recommends giving most children between 2 and 9 years of age two doses of the seasonal influenza vaccine 28 days apart. There are two approved types of vaccines available: one is a nasal spray, the other is a shot.
"We want to know which combination gives children the best protection against influenza," says Wright, "and since this is the time of year when parents are having their children vaccinated against the flu, we're looking for participants in this study to help us find the answer."
Participants in the study will be assigned at random to one of four possible vaccine delivery groups: nasal spray and nasal spray; shot and shot; nasal spray and shot; or shot and nasal spray. The vaccines are provided at no cost to participants. Compensation is offered, and participants will be given a gift certificate for each of the three blood draws associated with the study.
Wright, a professor of pediatrics at Dartmouth Medical School, is a world-renowned specialist in infectious diseases afflicting children with decades of experience eradicating polio and other conditions in the developing world.
For more information about the study or to enroll as a participant, call 603-650-5250 or email email@example.com